pI: 6.4184 |
Length (AA): 113 |
MW (Da): 13031 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | epimastigote. | Smircich P |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | metacyclic. | Smircich P |
Smircich P | Ribosome profiling reveals translation control as a key mechanism generating differential gene expression in Trypanosoma cruzi. |
Ortholog group members (OG5_127711)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G29850 | double-stranded DNA-binding protein |
Babesia bovis | BBOV_III003540 | conserved hypothetical protein |
Brugia malayi | Bm1_54975 | Double-stranded DNA-binding domain containing protein |
Candida albicans | CaO19.8332 | similar to human apoptosis-related, predicted DNA binding protein PDCD5 (NP_004699) |
Candida albicans | CaO19.713 | similar to human apoptosis-related, predicted DNA binding protein PDCD5 (NP_004699) |
Caenorhabditis elegans | CELE_D2005.3 | Protein D2005.3 |
Cryptosporidium hominis | Chro.40253 | apoptosis-related protein |
Cryptosporidium parvum | cgd4_2220 | possible double-stranded DNA-binding domain, small conserved protein |
Dictyostelium discoideum | DDB_G0278111 | hypothetical protein |
Drosophila melanogaster | Dmel_CG13072 | Programmed Cell Death 5 |
Echinococcus granulosus | EgrG_000425200 | programmed cell death protein 5 |
Entamoeba histolytica | EHI_191910 | hypothetical protein, conserved |
Entamoeba histolytica | EHI_198970 | hypothetical protein, conserved |
Echinococcus multilocularis | EmuJ_000425200 | programmed cell death protein 5 |
Giardia lamblia | GL50803_10679 | Hypothetical protein |
Homo sapiens | ENSG00000105185 | programmed cell death 5 |
Leishmania braziliensis | LbrM.28.2090 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_282040.1 | Double-stranded DNA-binding domain containing protein, putative |
Leishmania infantum | LinJ.28.2040 | hypothetical protein, conserved |
Leishmania major | LmjF.28.1920 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.28.1920 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_05987 | hypothetical protein |
Mus musculus | ENSMUSG00000030417 | programmed cell death 5 |
Mus musculus | 100042424 | predicted gene 3837 |
Neospora caninum | NCLIV_002640 | hypothetical protein |
Oryza sativa | 4339503 | Os05g0546500 |
Oryza sativa | 9269971 | Os05g0547850 |
Onchocerca volvulus | OVOC9314 | Programmed cell death protein 5 homolog |
Plasmodium berghei | PBANKA_0810500 | apoptosis-related protein, putative |
Plasmodium falciparum | PF3D7_0909300 | apoptosis-related protein |
Plasmodium knowlesi | PKNH_0707300 | apoptosis-related protein, putative |
Plasmodium vivax | PVX_098905 | apoptosis-related protein, putative |
Plasmodium yoelii | PY03132 | Unknown-related |
Saccharomyces cerevisiae | YMR074C | hypothetical protein |
Schistosoma japonicum | Sjp_0033620 | ko:K06875 pdcd5; programmed cell death 5, putative |
Schistosoma mansoni | Smp_058350 | programmed cell death protein |
Schmidtea mediterranea | mk4.000015.22 | Programmed cell death protein 5 |
Trypanosoma brucei gambiense | Tbg972.11.10100 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.11.9040 | conserved protein |
Trypanosoma cruzi | TcCLB.510899.19 | conserved protein |
Trypanosoma cruzi | TcCLB.507077.50 | conserved protein |
Theileria parva | TP03_0053 | hypothetical protein |
Trichomonas vaginalis | TVAG_390790 | programmed cell death, putative |
Trichomonas vaginalis | TVAG_185560 | programmed cell death, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.01.0780 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.01.0780 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb11.01.0780 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb11.01.0780 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Type | Source | Notes |
---|---|---|
soluble recombinant protein | Structural Genomics for Pathogenic Protozoa (SGPP) | Tcru008721; Recombinant protein: full-length; Source: T cruzi; conserved hypothetical protein ; |